Tinnitus Prevalence in the Adult Population-Results from the Gutenberg Health Study

Medicina (Kaunas). 2023 Mar 20;59(3):620. doi: 10.3390/medicina59030620.

Abstract

Background and Objectives: Tinnitus is a common symptom in medical practice, although data on its prevalence vary. As the underlying pathophysiological mechanism is still not fully understood, hearing loss is thought to be an important risk factor for the occurrence of tinnitus. The aim of this study was to assess tinnitus prevalence in a large German cohort and to determine its dependence on hearing impairment. Materials and Methods: The Gutenberg Health Study (GHS) is a population-based cohort study and representative for the population of Mainz and its district. Participants were asked whether they suffer from tinnitus and how much they are burdened by it. Extensive audiological examinations using bone- and air-conduction were also performed. Results: 4942 participants (mean age: 61.0, 2550 men and 2392 women) were included in the study. The overall prevalence of tinnitus was 26.1%. Men were affected significantly more often than women. The prevalence of tinnitus increased with age, peaking at ages 75 to 79 years. Considering only annoying tinnitus, the prevalence was 9.8%. Logistic regression showed that participants with severe to complete hearing loss (>65 dB) were more likely to have tinnitus. Conclusions: Tinnitus is a common symptom, and given demographic changes, its prevalence is expected to increase.

Keywords: audiology; cohort study; hearing loss; otology/neurotology.

MeSH terms

  • Adult
  • Aged
  • Cohort Studies
  • Deafness*
  • Female
  • Hearing Loss* / complications
  • Hearing Loss* / epidemiology
  • Humans
  • Male
  • Prevalence
  • Risk Factors
  • Tinnitus* / epidemiology
  • Tinnitus* / etiology

Grants and funding

The Gutenberg Health Study (GHS) is funded through the government of Rhineland-Palatinate (“Stiftung Rheinland-Pfalz für Innovation”, contract AZ 961-386261/733), the research programs “Wissen schafft Zukunft” and “Center for Translational Vascular Biology (CTVB)” of the Johannes Gutenberg-University of Mainz, and its contracts with Boehringer Ingelheim, and PHILIPS Medical Systems, including an unrestricted grant for the Gutenberg Health Study. Philipp S Wild is funded by the Federal Ministry of Education and Research (BMBF 01EO1503). Philipp S Wild and Thomas Münzel are PI of the German Center for Vascular Research (DZHK).